对,神经发育障碍和运动障碍的病例分析与脱水多利基二酸盐合成酶基因突变相关
Ting Lv1, Jun-Xian Fu1, Xiao-Yang Liu1
1Department of Pediatrics, The Affiliated Hospital of Inner Mongolia Medical University, No. 1 North Channel Road, Inner Mongolia, Hohhot 010050, China.
Seizure
|June 25, 2023
概括
脱水多利基二酸盐合成酶 (DHDDS) 基因的突变与婴儿和发育迟缓有关. 酸 (VPA) 在治疗这些与DHDDS相关的病例方面表现出有效性.
科学领域:
- 遗传学和分子生物学
- 神经学 神经学
- 生物化学 生物化学
背景情况:
- 脱基二酸盐合成酶 (DHDDS) 在美酸盐路径中至关重要.
- DHDDS中的突变与各种发育障碍有关,但基因型-表型相关性仍然不清楚.
研究的目的:
- 分析DHDDS突变在发育迟缓和中的作用.
- 描述DHDDS相关的基因型-表型特征.
- 总结和统计分析DHDDS基因突变相关的病例.
主要方法:
- 使用关键词的文献综述:DHDDS,,神经发育障碍.
- 分析了25个检索出来的病例,其中21个为奇平方测试提供了完整的数据.
- 临床特征的总结和统计分析.
主要成果:
- 由于DHDDS突变引起的发病通常发生在婴儿期,通常以肌细胞结核作为最初的症状.
- 通常与神经发育障碍和智力障碍有关;脑部MRI正常,但EEG发现异常.
- 酸 (VPA) 在治疗方面表现出良好的疗效.
结论:
- DHDDS基因突变与先天性糖化乱,视网膜色素炎和有关.
- 儿科DHDDS突变经常导致肌性,智力障碍和神经发育障碍.
- 诊断依赖于下一代测序或全外体测序;VPA是一种有益的治疗方法.
相关概念视频
Epilepsy and Seizures: Overview
228
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
228
Inborn Errors of Metabolism
206
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
206
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Parkinson's Disease: Overview
607
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
607


